Phase 1/2 study of weekly paclitaxel with or without alisertib, an investigational aurora a kinase inhibitor: Phase 1 results in patients with recurrent epithelial ovarian, fallopian tube, primary peritoneal, or breast cancer
Saved in:
| Title: | Phase 1/2 study of weekly paclitaxel with or without alisertib, an investigational aurora a kinase inhibitor: Phase 1 results in patients with recurrent epithelial ovarian, fallopian tube, primary peritoneal, or breast cancer |
|---|---|
| Authors: | Falchook, G.1, Goff, B.2, Kurzrock, R.1, Gray, H.2, Martin, L.3, Coleman, R.1, Xiao, H.4, Zhou, X.4, Benaim, E.4, Schilder, R.5 |
| Source: | Gynecologic Oncology. Mar2012 Supplement, Vol. 125, pS31-S32. 0p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 73498129 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Phase 1/2 study of weekly paclitaxel with or without alisertib, an investigational aurora a kinase inhibitor: Phase 1 results in patients with recurrent epithelial ovarian, fallopian tube, primary peritoneal, or breast cancer – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Falchook%2C+G%2E%22">Falchook, G.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Goff%2C+B%2E%22">Goff, B.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Kurzrock%2C+R%2E%22">Kurzrock, R.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Gray%2C+H%2E%22">Gray, H.</searchLink><relatesTo>2</relatesTo><br /><searchLink fieldCode="AR" term="%22Martin%2C+L%2E%22">Martin, L.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Coleman%2C+R%2E%22">Coleman, R.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Xiao%2C+H%2E%22">Xiao, H.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Zhou%2C+X%2E%22">Zhou, X.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Benaim%2C+E%2E%22">Benaim, E.</searchLink><relatesTo>4</relatesTo><br /><searchLink fieldCode="AR" term="%22Schilder%2C+R%2E%22">Schilder, R.</searchLink><relatesTo>5</relatesTo> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Gynecologic+Oncology%22">Gynecologic Oncology</searchLink>. Mar2012 Supplement, Vol. 125, pS31-S32. 0p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=73498129 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ygyno.2011.12.071 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 0 StartPage: S31 Titles: – TitleFull: Phase 1/2 study of weekly paclitaxel with or without alisertib, an investigational aurora a kinase inhibitor: Phase 1 results in patients with recurrent epithelial ovarian, fallopian tube, primary peritoneal, or breast cancer Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Falchook, G. – PersonEntity: Name: NameFull: Goff, B. – PersonEntity: Name: NameFull: Kurzrock, R. – PersonEntity: Name: NameFull: Gray, H. – PersonEntity: Name: NameFull: Martin, L. – PersonEntity: Name: NameFull: Coleman, R. – PersonEntity: Name: NameFull: Xiao, H. – PersonEntity: Name: NameFull: Zhou, X. – PersonEntity: Name: NameFull: Benaim, E. – PersonEntity: Name: NameFull: Schilder, R. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 03 Text: Mar2012 Supplement Type: published Y: 2012 Identifiers: – Type: issn-print Value: 00908258 Numbering: – Type: volume Value: 125 Titles: – TitleFull: Gynecologic Oncology Type: main |
| ResultId | 1 |
